Chao, Tze-Fan <br/><br/>
Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations.  [electronic resource] 

 -  Thrombosis and haemostasis  03 2020 
 - 366-368 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1055/s-0040-1702230  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants<br/>Atrial Fibrillation<br/>Humans<br/>International Normalized Ratio<br/>Warfarin